can you switch from semaglutide to tirzepatide immediately Switching Between and Tirzepatide: Efficacy, Dosing Protocols, and What Expect What to Know When Switching

Aurora, CO

This peptide has achieved an average of 15% body weight loss in clinical trials

Call to schedule a free consultation with our attorney today at Caudill Law.

And what they started reporting didn't always match what the clinical trials described

Women with polycystic ovary syndrome face unique metabolic challenges that make weight management difficult

Clinical data supporting the dose increase demonstrated that patients on the higher dose achieved meaningfully greater weight reduction with some trial arms showing average body weight loss approaching 25%, closing the efficacy gap with tirzepatide that has driven a significant portion of Wegovy's market share erosion in 2025 and 2026